This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zimrin, D. Articles by Fung, H. L. Search for Related Content PubMed PubMed Citation Articles by Zimrin, D. Articles by Fung, H. L.

Circulation, Vol 77, 1376-1384, Copyright © 1988 by American Heart Association

ARTICLES

Antianginal effects of intravenous nitroglycerin over 24 hours

D Zimrin, N Reichek, KT Bogin, G Aurigemma, P Douglas, B Berko and HL Fung
Department of Medicine, Hospital of the University of Pennsylvania School of Medicine, Philadelphia 19104.

To determine the constancy of hemodynamic and antianginal effects of the constant infusion of intravenous nitroglycerin (NTG) and their relationship to infusion rate and plasma NTG concentration, we administered maximal tolerated doses of intravenous NTG (range 10 to 120 micrograms/min, mean = 52 +/- 33 micrograms/min) and placebo to 10 patients with chronic stable angina for 25 hr each in a randomized, double-blind fashion. Sublingual NTG (0.4 mg) was given at 24.5 hr of infusion as a positive control. Bicycle exercise time (NIH protocol), blood pressure, heart rate, exercise ST response, and venous plasma NTG were determined before and at 1, 4, 8, 24, and 24.5 hr. Plasma NTG was linearly related to infusion rate, reached a steady state within 15 min and was unchanged over 24 hr (mean = 5.5 +/- 1.2 ng/ml). Mean plasma NTG clearance was 9.3 liters/min. However, during dose titration, patients demonstrated different relationships between plasma NTG and hemodynamic effects, with widely varying slopes and intercepts. Intravenous NTG produced a sustained reduction in blood pressure and a rise in heart rate at rest, and a reduction in blood pressure during submaximal exercise at as late as 24 hr, associated with reduced submaximal ST segment abnormality. In contrast, exercise tolerance to onset of angina showed a marked initial increase on intravenous NTG but fell progressively and did not differ from that with placebo at 24 hr. Increased exercise tolerance was associated with an increase in maximal heart rate and double product (heart rate X blood pressure), suggesting that direct coronary vasodilation and/or reduced left ventricular volume were the principal determinants of increased exercise tolerance.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. Hill, H. Takano, X.-L. Tang, E. Kodani, G. Shirk, and R. Bolli Nitroglycerin Induces Late Preconditioning Against Myocardial Infarction in Conscious Rabbits Despite Development of Nitrate Tolerance Circulation, August 7, 2001; 104(6): 694 - 699. [Abstract] [Full Text] [PDF]

				M. J. Mihm, C. M. Coyle, L. Jing, and J. A. Bauer Vascular Peroxynitrite Formation during Organic Nitrate Tolerance J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 194 - 198. [Abstract] [Full Text]

				H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1194 - 1200. [Abstract] [Full Text] [PDF]

				H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita Preventive effects of carvedilol on nitrate tolerance--a randomized, double-blind, placebo-controlled comparative study between carvedilol and arotinolol J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1201 - 1206. [Abstract] [Full Text] [PDF]

				H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita Randomized, Double-Blind, Placebo-Controlled Study of Ascorbate on the Preventive Effect of Nitrate Tolerance in Patients With Congestive Heart Failure Circulation, March 10, 1998; 97(9): 886 - 891. [Abstract] [Full Text] [PDF]

				H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita Randomized, Double-Blind, Placebo-Controlled Study of Supplemental Vitamin E on Attenuation of the Development of Nitrate Tolerance Circulation, October 21, 1997; 96(8): 2545 - 2550. [Abstract] [Full Text]

				J. D. Parker, A. B. Parker, B. Farrell, and J. O. Parker The Effect of Hydralazine on the Development of Tolerance to Continuous Nitroglycerin J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 866 - 875. [Abstract] [Full Text]

				P. Zhang, A. Ohara, T. Mashimo, J. Sun, S. Shibuta, K. Takada, H. Kosaka, M. Terada, and I. Yoshiya Cardiovascular Effects of an Ultra–Short-Acting Nitric Oxide–Releasing Compound, Zwitterionic Diamine/NO Adduct, in Dogs Circulation, November 1, 1996; 94(9): 2235 - 2240. [Abstract] [Full Text]

				J. B. Laursen, A. Mulsch, S. Boesgaard, P. Mordvintcev, S. Trautner, N. Gruhn, J. E. Nielsen-Kudsk, R. Busse, and J. Aldershvile In Vivo Nitrate Tolerance Is Not Associated With Reduced Bioconversion of Nitroglycerin to Nitric Oxide Circulation, November 1, 1996; 94(9): 2241 - 2247. [Abstract] [Full Text]

				U. Thadani Nitrate Therapy and the Development of Tolerance Arch Fam Med, August 1, 1993; 2(8): 880 - 885. [Abstract] [PDF]

				U. Elkayam Tolerance to Organic Nitrates: Evidence, Mechanisms, Clinical Relevance, and Strategies for Prevention Ann Intern Med, April 15, 1991; 114(8): 667 - 677. [Abstract] [PDF]